HUP0302580A2 - Antibakteriális hatású új heterociklusos vegyületek, eljárás előállításukra és a heterociklusos vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Antibakteriális hatású új heterociklusos vegyületek, eljárás előállításukra és a heterociklusos vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0302580A2 HUP0302580A2 HU0302580A HUP0302580A HUP0302580A2 HU P0302580 A2 HUP0302580 A2 HU P0302580A2 HU 0302580 A HU0302580 A HU 0302580A HU P0302580 A HUP0302580 A HU P0302580A HU P0302580 A2 HUP0302580 A2 HU P0302580A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- carbon atom
- carbon
- atom
- unsubstituted
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 18
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 150000001721 carbon Chemical group 0.000 abstract 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 abstract 2
- -1 azido- Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000001769 aryl amino group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- XNVMFDGFXSZPDU-UHFFFAOYSA-N cyano nitroformate Chemical compound [O-][N+](=O)C(=O)OC#N XNVMFDGFXSZPDU-UHFFFAOYSA-N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical group OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002540 isothiocyanates Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000006574 non-aromatic ring group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000003441 thioacyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
A találmány tárgya az (I) általános képletű - ahol R1 jelentésehalogénatom, azido-, tioalkohol-, izotiocianát, OR4, NHR4 vagy N(R4)2általános képletű csoport, ahol R4 jelentése hidrogénatom vagyhelyettesítetlen vagy helyettesített alábbi csoport: acil-, tioacil-,1-6 szénatomos alkoxi-karbonil-, 3-6 szénatomos cikloalkoxi-tiokarbonil-, 2-6 szénatomos alkenil-oxi-karbonil-, 2-6 szénatomosalkenil-karbonil-, aril-oxi-karbonil-, 1-6 szénatomos alkoxi-tiokarbonil-, 2-6 szénatomos alkenil-oxi-tiokarbonil-, aril-oxi-tiokarbonil-csoport, -C(=O)C(=O)-(1-6 szénatomos)alkil, -C(=O)-C(=O)-aril, -C(=O)-C(=O)-(1-6 szénatomos)alkoxi, -C(=O)-C(=O)-aril-oxi, -(C=S)-S-(1-6 szénatomos)alkil, -(C=S)-NH2, -(C=)-NH-(1-6szénatomos)alkil, -C(=S)- N-((1-6 szénatomos)alkil)2, -C(=S)-NH-(2-6szénatomos)alkenil, -(C=S)-(C=O)-(1-6 szénatomos)alkoxi, -(C=S)-(C=O)-aril-oxi, -C(=S)-O-(C=O)-(1-6 szénatomos)alkil, C(=S)-C(=S)-(1-6szénatomos)alkil, -C(=S)-C(=S)-aril általános képletű csoport,tiomorfolinil-tiokarbonil- vagy pirrolidinil-tiokarbonil-csoport; R2és R3 jelentése egymástól függetlenül hidrogén-, halogénatom, 1-6szénatomos alkil-, halogénezett, 1-6 szénatomos alkil-, ciano-,nitro-, SRa, NRa, ORa általános képletű csoport, melyen belül Rajelentése helyettesített vagy helyettesítetlen, 1-6 szénatomos alkil-vagy halogénezett, 1-6 szénatomos alkilcsoport; Z jelentése kén-,oxigénatom, =CH vagy NRb képletű, illetve általános képletű csoport,melyen belül Rb jelentése hidrogénatom, helyettesített vagyhelyettesítetlen, 1-6 szénatomos alkil-, 2-6 szénatomos alkenil-, 1-6szénatomos cikloalkil-, 1-6 szénatomos alkoxi-, aril-, aralkil-, aril-oxi-, 1-6 szénatomos alkil-karbonil-, aril-karbonil-, 1-6 szénatomosalkoxi-karbonil- vagy aril-oxi-karbonil-csoport; Y1 jelentése =O vagy=S képletű csoport; Y2 és Y3 jelentése egymástól függetlenülhidrogén-, halogénatom, ciano-, nitro-, formit-, hidroxil-, amino-,=O, =S képletű csoport vagy helyettesítetlen vagy helyettesítettalábbi csoport: 1-6 szénatomos alkil-, 1-6 szénatomos hidroxi-alkil-,1-6 szénatomos alkoxi-(1-6 szénatomos)alkil-, 1-6 szénatomos alkoxi-karbonil-, karboxi-(1-6 szénatomos)alkil, 1-6 szénatomos alkil-szulfonil-, 1-6 szénatomos alkil-karbonil-amino-(1-6szénatomos)alkil-, aril-karbonil-amino-(1-6 szénatomos)alkil-, 1-6szénatomos alkil-karbonil-oxi-(1-6 szénatomos)alkil-, 1-6 szénatomosamino-alkil-, 1-6 szénatomos monoalkil-amino-, di(1-6szénatomos)alkil-amino-, aril-amino-, 1-6 szénatomos alkoxi-, aril-,aril-oxi-, aralkil-, heteroaril-, heteroaralkil-, heterociklusos vagyheterocikloalkil-csoport; vagy Y2 és Y3, amikor szomszédosszénatomokon helyezkedik el, együtt alkothatnak egy helyettesítettvagy helyettesítetlen, 5- vagy 6 tagú, aromás vagy nemaromás gyűrűsszerkezetet, mely adott esetben egy vagy két heteroatomot
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1124MA2000 | 2000-12-26 | ||
| IN15MA2001 | 2001-01-15 | ||
| PCT/IN2001/000227 WO2002051819A2 (en) | 2000-12-26 | 2001-12-26 | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0302580A2 true HUP0302580A2 (hu) | 2003-11-28 |
Family
ID=26324889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302580A HUP0302580A2 (hu) | 2000-12-26 | 2001-12-26 | Antibakteriális hatású új heterociklusos vegyületek, eljárás előállításukra és a heterociklusos vegyületeket tartalmazó gyógyszerkészítmények |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7030148B2 (hu) |
| EP (1) | EP1345913A2 (hu) |
| JP (1) | JP2004525876A (hu) |
| KR (1) | KR20030063472A (hu) |
| CN (1) | CN1656083A (hu) |
| BG (1) | BG108022A (hu) |
| BR (1) | BR0116571A (hu) |
| CA (1) | CA2433138A1 (hu) |
| CZ (1) | CZ20031799A3 (hu) |
| EE (1) | EE200300254A (hu) |
| HR (1) | HRP20030522A2 (hu) |
| HU (1) | HUP0302580A2 (hu) |
| IL (1) | IL156662A0 (hu) |
| MX (1) | MXPA03005822A (hu) |
| NO (1) | NO20032926L (hu) |
| NZ (1) | NZ526716A (hu) |
| PL (1) | PL363616A1 (hu) |
| RU (1) | RU2322444C2 (hu) |
| SK (1) | SK8202003A3 (hu) |
| WO (1) | WO2002051819A2 (hu) |
| YU (1) | YU52403A (hu) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002329393B2 (en) | 2001-09-11 | 2008-06-12 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| US20060293315A1 (en) * | 2001-12-21 | 2006-12-28 | Dr. Reddy's Laboratories Ltd. | Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
| US6914058B2 (en) * | 2002-01-18 | 2005-07-05 | Dr. Reddy's Laboratories, Limited | Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7141561B2 (en) | 2002-07-25 | 2006-11-28 | Sanofi-Aventis Deutschland Gmbh | Substituted diaryl heterocycles, process for their preparation and their use as medicaments |
| WO2004089944A1 (en) * | 2003-04-07 | 2004-10-21 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| EP1646629B1 (en) | 2003-07-02 | 2010-06-23 | Merck Sharp & Dohme Corp. | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| US20070185132A1 (en) * | 2003-07-02 | 2007-08-09 | Yasumichi Fukuda | Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo |
| WO2005035528A2 (en) * | 2003-10-14 | 2005-04-21 | Dr. Reddy's Laboratories Ltd. | Triazole derivatives as antibacterial agents |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| CA2602073A1 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| PL1928454T3 (pl) | 2005-05-10 | 2015-03-31 | Intermune Inc | Pochodne pirydonu do modulowania układu kinazy białkowej aktywowanego stresem |
| US8178683B2 (en) * | 2007-08-06 | 2012-05-15 | Micurx Pharmaceuticals, Inc. | Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| CA3034994A1 (en) | 2008-06-03 | 2009-12-10 | Intermune, Inc. | Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders |
| EP2326631A4 (en) * | 2008-08-18 | 2012-03-21 | Univ Yale | MODULATORS OF MIF |
| US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| US8426389B2 (en) | 2009-02-03 | 2013-04-23 | Trius Therapeutics, Inc. | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| CN101798302B (zh) * | 2009-02-06 | 2014-11-05 | 上海盟科药业有限公司 | 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺 |
| WO2014045292A1 (en) * | 2012-09-20 | 2014-03-27 | Symed Labs Limited | Improved process for the preparation of linezolid intermediate |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| EP3107923B1 (en) | 2014-02-21 | 2021-11-03 | Shanghai MicuRx Pharmaceutical Co., Ltd. | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration |
| KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
| GB2550437B (en) * | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
| WO2020021468A1 (en) | 2018-07-25 | 2020-01-30 | Cadila Healthcare Limited | Substituted oxazolidinones for the treatment of mammalian infections |
| WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
| CN110301433A (zh) * | 2019-07-25 | 2019-10-08 | 河南精怡达生物科技有限公司 | 一种含有微量元素组合的猪精液体外常温保存剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2987505A (en) * | 1958-03-04 | 1961-06-06 | Gen Aniline & Film Corp | Compositions of polymeric nu-vinyl-2-oxazolidone and halogens |
| US3651079A (en) | 1968-11-25 | 1972-03-21 | Colgate Palmolive Co | 1-aryl-5-hydroxyalkyl-hydantoins |
| GB1408010A (en) | 1972-11-20 | 1975-10-01 | Geistlich Soehne Ag | Sulphamoylphenyl-imidazolidinones |
| US4174958A (en) | 1978-01-09 | 1979-11-20 | Shell Oil Company | Anilide derivative herbicides |
| FR2571364B1 (fr) | 1984-10-09 | 1987-07-17 | Oreal | Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| RU2134692C1 (ru) | 1994-10-26 | 1999-08-20 | Фармация Энд Апджон Компани | Антимикробные фенилоксазолидиноны |
| US6124334A (en) | 1995-02-03 | 2000-09-26 | Pharmacia & Upjohn Company | Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| US6087496A (en) * | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
| JPH11322729A (ja) * | 1998-03-09 | 1999-11-24 | Hokuriku Seiyaku Co Ltd | ジチオカルバミド酸誘導体 |
| JP2003513885A (ja) | 1999-07-28 | 2003-04-15 | ファルマシア・アンド・アップジョン・カンパニー | オキサゾリジノンおよび抗感染薬としてのその使用 |
| GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
-
2001
- 2001-11-26 YU YU52403A patent/YU52403A/sh unknown
- 2001-12-21 US US10/032,392 patent/US7030148B2/en not_active Expired - Fee Related
- 2001-12-26 CZ CZ20031799A patent/CZ20031799A3/cs unknown
- 2001-12-26 CA CA002433138A patent/CA2433138A1/en not_active Abandoned
- 2001-12-26 EP EP01995805A patent/EP1345913A2/en not_active Withdrawn
- 2001-12-26 JP JP2002552914A patent/JP2004525876A/ja not_active Withdrawn
- 2001-12-26 MX MXPA03005822A patent/MXPA03005822A/es not_active Application Discontinuation
- 2001-12-26 KR KR10-2003-7008637A patent/KR20030063472A/ko not_active Application Discontinuation
- 2001-12-26 PL PL01363616A patent/PL363616A1/xx not_active Application Discontinuation
- 2001-12-26 EE EEP200300254A patent/EE200300254A/xx unknown
- 2001-12-26 CN CNA018224210A patent/CN1656083A/zh active Pending
- 2001-12-26 WO PCT/IN2001/000227 patent/WO2002051819A2/en active IP Right Grant
- 2001-12-26 HU HU0302580A patent/HUP0302580A2/hu unknown
- 2001-12-26 SK SK820-2003A patent/SK8202003A3/sk not_active Application Discontinuation
- 2001-12-26 NZ NZ526716A patent/NZ526716A/en unknown
- 2001-12-26 BR BR0116571-2A patent/BR0116571A/pt not_active IP Right Cessation
- 2001-12-26 IL IL15666201A patent/IL156662A0/xx unknown
- 2001-12-26 RU RU2003123104/04A patent/RU2322444C2/ru not_active IP Right Cessation
-
2003
- 2003-06-25 NO NO20032926A patent/NO20032926L/no unknown
- 2003-06-26 HR HR20030522A patent/HRP20030522A2/hr not_active Application Discontinuation
- 2003-07-22 BG BG108022A patent/BG108022A/bg unknown
- 2003-08-01 US US10/632,950 patent/US7183301B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002051819A9 (en) | 2003-08-07 |
| US20040059120A1 (en) | 2004-03-25 |
| WO2002051819A2 (en) | 2002-07-04 |
| US20030065175A1 (en) | 2003-04-03 |
| CZ20031799A3 (cs) | 2004-02-18 |
| EE200300254A (et) | 2003-12-15 |
| NO20032926L (no) | 2003-08-25 |
| NO20032926D0 (no) | 2003-06-25 |
| CA2433138A1 (en) | 2002-07-04 |
| US7183301B2 (en) | 2007-02-27 |
| BG108022A (bg) | 2004-09-30 |
| JP2004525876A (ja) | 2004-08-26 |
| IL156662A0 (en) | 2004-01-04 |
| NZ526716A (en) | 2005-08-26 |
| RU2003123104A (ru) | 2005-03-10 |
| RU2322444C2 (ru) | 2008-04-20 |
| CN1656083A (zh) | 2005-08-17 |
| YU52403A (sh) | 2006-03-03 |
| PL363616A1 (en) | 2004-11-29 |
| MXPA03005822A (es) | 2004-05-04 |
| SK8202003A3 (en) | 2004-07-07 |
| WO2002051819A3 (en) | 2002-12-05 |
| KR20030063472A (ko) | 2003-07-28 |
| EP1345913A2 (en) | 2003-09-24 |
| HRP20030522A2 (en) | 2005-06-30 |
| BR0116571A (pt) | 2004-03-02 |
| US7030148B2 (en) | 2006-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302580A2 (hu) | Antibakteriális hatású új heterociklusos vegyületek, eljárás előállításukra és a heterociklusos vegyületeket tartalmazó gyógyszerkészítmények | |
| CO5690597A2 (es) | Derivados de hexahidropirazino[1,2-a]pirimidina-4,7-diona sustituidos, metodo para producirlos y sus uso cxomo medicamentos | |
| HUP0303729A2 (hu) | Akridinszármazékok és azok gyógyszerként történő alkalmazása és eljárás az előállításukra | |
| HUP0300350A2 (hu) | Új 3-amino-azetidin-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0300618A2 (hu) | Adamantánszármazékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
| EP0860428A3 (en) | Sulphonamide derivatives | |
| HUP0302918A2 (hu) | Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására | |
| AU2760892A (en) | Substituted beta -amino acid derivatives useful as platelet aggregation inhibitors | |
| HUP0004529A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
| HUP0300190A2 (en) | Tricyclic compounds as hiv reverse transcriptase inhibitors and pharmaceutical compositions containing them and their preparation | |
| KR940014368A (ko) | 신규한 나프탈렌 유도체 | |
| AR067181A1 (es) | Inhibidores de transcriptasa inversa de hiv, composicion farmaceutica, uso del compuesto para preparar un medicamento, agente de combinacion farmaceutica y metodo de inhibicion de la replicacion de un retrovirus | |
| AU3464297A (en) | Piperazine derivatives and process for the preparation thereof | |
| HUP0400246A2 (hu) | 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra | |
| HUP0300444A2 (hu) | Kálciumblokkolót tartalmazó stabilizált gyógyszerkészítmények | |
| HUP0203184A2 (hu) | Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BG102701A (en) | 2-hetaroylcyclohexan-1,3-dions | |
| HUP0105105A2 (hu) | Gyulladásgátló hatású makrolidok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0203524A2 (hu) | Daganatellenes hatású 2- (1H-indol-3-il)-2-oxo-acetamidok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0100184A2 (hu) | Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0400806A2 (hu) | Heterokondenzált (gamma)-laktám-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
| HUP0303533A2 (hu) | Adenozin A1 receptor agonista adenozinszármazékok | |
| KR890009867A (ko) | 비 펩타이드성 레닌 억제제 | |
| BG105855A (en) | 2-aminopyridines containing fused ring substituents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |